Panacea Biotec Ltd (PANACEABIO) - Financial and Strategic SWOT Analysis Review
September 2018
43
About the Report
About the Report
Panacea Biotec Ltd (PANACEABIO)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities-A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Panacea Biotec Ltd (Panacea) is a research-based health management company which focuses on manufactures and commercializes pharmaceuticals; biopharmaceuticals; natural, and indigenous products; and vaccines. Its vaccines portfolio includes paediatric vaccines, including trivalent and monovalent oral polio vaccine, and Enivac HB vaccine; and combinative vaccines, including Easyfive-TT (DTwP-HepB-Hib), Novohib (haemophilus typeb conjugate vaccine IP) and Polprotec (inactivated poliomyelitis vaccine). Its pharmaceutical formulations span the therapeutic areas of oncology, nephrology, pain management, diabetes management, and organ transplantation. The company also offers contract research and manufacturing services. Panacea operates research and development centers and manufacturing facilities. It has subsidiaries in India, Switzerland and Germany. Panacea is headquartered in New Delhi, India.
Panacea Biotec Ltd Key Recent Developments
Mar 09,2018: Panacea Biotec Announces Receipt of Establishment Inspection Report (EIR) from USFDA
Oct 17,2017: Panacea Biotec receives Certificate of GMP Compliance with manufacturing authorizations for 22 medicinal products from State Service of Ukraine on Medicines and Drugs Control
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Panacea Biotec Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
Indus Biotech Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Elder Pharmaceuticals Ltd
Dalas Biotech
Cadila Healthcare Ltd
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1-About the Company 6
Panacea Biotec Ltd-Key Facts 6
Panacea Biotec Ltd-Key Employees 7
Panacea Biotec Ltd-Key Employee Biographies 8
Panacea Biotec Ltd-Major Products and Services 9
Panacea Biotec Ltd-History 14
Panacea Biotec Ltd-Company Statement 17
Panacea Biotec Ltd-Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 19
Section 2-Company Analysis 20
Company Overview 20
Panacea Biotec Ltd-Business Description 21
Business Segment: Formulations 21
Overview 21
Performance 21
Business Segment: Research and Development 21
Performance 21
Business Segment: Vaccines 22
Overview 22
Performance 22
Geographical Segment: Domestic 22
Performance 22
Geographical Segment: Overseas 22
Performance 22
R&D Overview 22
Panacea Biotec Ltd-SWOT Analysis 23
SWOT Analysis-Overview 23
Panacea Biotec Ltd-Strengths 23
Panacea Biotec Ltd-Weaknesses 24
Panacea Biotec Ltd-Opportunities 25
Panacea Biotec Ltd-Threats 26
Panacea Biotec Ltd-Key Competitors 27
Section 3-Company Financial Ratios 28
Financial Ratios-Capital Market Ratios 28
Financial Ratios-Annual Ratios 29
Performance Chart 32
Financial Performance 32
Financial Ratios-Ratio Charts 33
Section 4-Company's Lifesciences Financial Deals and Alliances 34
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 35
Panacea Biotec Ltd, Recent Deals Summary 36
Section 5-Company's Recent Developments 37
Mar 09, 2018: Panacea Biotec Announces Receipt of Establishment Inspection Report (EIR) from USFDA 37
Oct 17, 2017: Panacea Biotec receives Certificate of GMP Compliance with manufacturing authorizations for 22 medicinal products from State Service of Ukraine on Medicines and Drugs Control 38
Section 6-Appendix 39
Methodology 39
Ratio Definitions 39
About GlobalData 43
Contact Us 43
Disclaimer 43
List of Figure
List of Figures
Panacea Biotec Ltd, Performance Chart (2014-2018) 32
Panacea Biotec Ltd, Ratio Charts 33
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 35
List of Table
List of Tables
Panacea Biotec Ltd, Key Facts 6
Panacea Biotec Ltd, Key Employees 7
Panacea Biotec Ltd, Key Employee Biographies 8
Panacea Biotec Ltd, Major Products and Services 9
Panacea Biotec Ltd, History 14
Panacea Biotec Ltd, Other Locations 18
Panacea Biotec Ltd, Subsidiaries 18
Panacea Biotec Ltd, Joint Venture 19
Panacea Biotec Ltd, Key Competitors 27
Panacea Biotec Ltd, Ratios based on current share price 28
Panacea Biotec Ltd, Annual Ratios 29
Panacea Biotec Ltd, Annual Ratios (Cont...1) 30
Panacea Biotec Ltd, Annual Ratios (Cont...2) 31
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 35
Panacea Biotec Ltd, Recent Deals Summary 36
Currency Codes 39
Capital Market Ratios 39
Equity Ratios 40
Profitability Ratios 40
Cost Ratios 41
Liquidity Ratios 41
Leverage Ratios 42
Efficiency Ratios 42
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.